NEOPLASM MALIGNANT

Clinical trials for NEOPLASM MALIGNANT explained in plain language.

Never miss a new study

Get alerted when new NEOPLASM MALIGNANT trials appear

Sign up with your email to follow new studies for NEOPLASM MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1 Terminated 1

New drug tested for Tough-to-Treat cancers

Disease control Completed

This study tested a new drug called STRO-002 in Chinese adults with advanced solid tumors, including ovarian and endometrial cancer, that had stopped responding to standard treatments. The main goals were to find a safe dose, see how the body processes the drug, and check for ear…

Matched conditions: NEOPLASM MALIGNANT

Phase: PHASE1, PHASE2 • Sponsor: Tasly Pharmaceutical Group Co., Ltd • Aim: Disease control

Last updated Apr 16, 2026 12:47 UTC

NEOPLASM MALIGNANT

Get alerted when new NEOPLASM MALIGNANT trials appear

New drug tested for Tough-to-Treat cancers